• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LSD1 是通过调节细胞干性来治疗癌症的有希望的靶点。

LSD1 is a promising target to treat cancers by modulating cell stemness.

机构信息

School of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, PR China.

School of Pharmacy, Nantong University, Nantong 226001, PR China.

出版信息

Biochem Pharmacol. 2024 Nov;229:116549. doi: 10.1016/j.bcp.2024.116549. Epub 2024 Sep 19.

DOI:10.1016/j.bcp.2024.116549
PMID:39304105
Abstract

As the first discovered histone demethylase, LSD1 plays a vital role in maintaining pathological processes such as cancer, infection, and immune diseases. Based on previous researches, LSD1 is highly expressed in sorts of tumor cells such as acute myeloid leukemia, non-small cell lung cancer, prostate cancer, breast cancer and gastric cancer, etc. Therefore, targeting LSD1 is a prospective strategy for tumor treatment. Cancer stem cells could preserve self-renewal, cell proliferation, cell migration and malignant phenotype. So, the reduction of tumor cell stemness can effectively inhibit the growth of tumor cells, which may be a new strategy for the treatment of cancers. Up to now, there exist many researches confirming the significant role of LSD1 in regulating the stemness characteristics such as embryonic stem cells differentiation. Many reports show that inhibition of LSD1 effectively decreases the property of cancer cell stemness. However, there lacks a detailed review about the relationship between LSD1 and cancer cell stemness. Herein, in this review, we summarized the mechanisms how LSD1 regulates cell stemness comprehensively. In addition, some related inhibitors targeting LSD1 to reduce the proliferation characteristics of cancer stem cells are also described.

摘要

作为首个被发现的组蛋白去甲基化酶,LSD1 在维持癌症、感染和自身免疫性疾病等病理过程中起着至关重要的作用。基于先前的研究,LSD1 在各种肿瘤细胞中高度表达,如急性髓系白血病、非小细胞肺癌、前列腺癌、乳腺癌和胃癌等。因此,靶向 LSD1 是肿瘤治疗的一种有前景的策略。肿瘤干细胞可以保持自我更新、细胞增殖、细胞迁移和恶性表型。因此,减少肿瘤细胞干性可以有效地抑制肿瘤细胞的生长,这可能是癌症治疗的一种新策略。到目前为止,有许多研究证实 LSD1 在调节干细胞特性(如胚胎干细胞分化)方面具有重要作用。许多报告表明,抑制 LSD1 能有效降低癌细胞干性。然而,目前缺乏关于 LSD1 与癌细胞干性之间关系的详细综述。因此,在这篇综述中,我们全面总结了 LSD1 调节细胞干性的机制。此外,还描述了一些针对 LSD1 的相关抑制剂,这些抑制剂可以减少癌症干细胞的增殖特性。

相似文献

1
LSD1 is a promising target to treat cancers by modulating cell stemness.LSD1 是通过调节细胞干性来治疗癌症的有希望的靶点。
Biochem Pharmacol. 2024 Nov;229:116549. doi: 10.1016/j.bcp.2024.116549. Epub 2024 Sep 19.
2
Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells.敲低 LSD1 抑制结直肠肿瘤干细胞的干性特征。
Braz J Med Biol Res. 2020 Jun 3;53(7):e9230. doi: 10.1590/1414-431X20209230. eCollection 2020.
3
A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.赖氨酸特异性去甲基化酶1及其在癌症中的作用的全面综述。
Epigenomics. 2017 Aug;9(8):1123-1142. doi: 10.2217/epi-2017-0022. Epub 2017 Jul 12.
4
Targeting LSD1 for acute myeloid leukemia (AML) treatment.针对急性髓系白血病(AML)的 LSD1 靶向治疗。
Pharmacol Res. 2021 Feb;164:105335. doi: 10.1016/j.phrs.2020.105335. Epub 2020 Dec 4.
5
Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.新型组蛋白去甲基化酶 LSD1 抑制剂选择性靶向具有多能干细胞特性的癌细胞。
Cancer Res. 2011 Dec 1;71(23):7238-49. doi: 10.1158/0008-5472.CAN-11-0896. Epub 2011 Oct 5.
6
Advances toward LSD1 inhibitors for cancer therapy.用于癌症治疗的 LSD1 抑制剂的研究进展。
Future Med Chem. 2017 Jul;9(11):1227-1242. doi: 10.4155/fmc-2017-0068. Epub 2017 Jul 19.
7
Pharmacological Inhibition of LSD1 for Cancer Treatment.LSD1 的药理学抑制在癌症治疗中的应用。
Molecules. 2018 Dec 4;23(12):3194. doi: 10.3390/molecules23123194.
8
Targeting LSD1 in cancer: Molecular elucidation and recent advances.靶向 LSD1 在癌症中的作用:分子解析与最新进展。
Cancer Lett. 2024 Aug 28;598:217093. doi: 10.1016/j.canlet.2024.217093. Epub 2024 Jul 4.
9
Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.新型赖氨酸特异性去甲基酶 1(LSD1)和组蛋白去乙酰化酶(HDAC)双重抑制剂的设计、合成及生物评价用于胃癌治疗。
Eur J Med Chem. 2021 Aug 5;220:113453. doi: 10.1016/j.ejmech.2021.113453. Epub 2021 Apr 25.
10
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.基于三氮唑-二硫代氨基甲酸盐的赖氨酸特异性去甲基化酶 1(LSD1)选择性抑制剂抑制胃癌细胞生长、侵袭和迁移。
J Med Chem. 2013 Nov 14;56(21):8543-60. doi: 10.1021/jm401002r. Epub 2013 Nov 1.